Effective Delivering Method of Umbilical Cord Blood Stem Cells in Cutaneous Wound Healing

제대혈 유래 중간엽 줄기 세포를 이용한 피부 창상 치료시 세포 투여 방법에 따른 창상치유 효과의 비교

  • Park, Sang Eun (Dept. of Plastic & Reconstructive Surgery, Yonsei University. College of Medicine, Institute for Human Tissue Restoration) ;
  • Han, Seung Bum (Dept. of Plastic & Reconstructive Surgery, Yonsei University. College of Medicine, Institute for Human Tissue Restoration) ;
  • Rah, Dong Kyun (Dept. of Plastic & Reconstructive Surgery, Yonsei University. College of Medicine, Institute for Human Tissue Restoration) ;
  • Lew, Dae Hyun (Dept. of Plastic & Reconstructive Surgery, Yonsei University. College of Medicine, Institute for Human Tissue Restoration)
  • 박상은 (연세대학교 성형외과학 교실, 인체조직복원연구소) ;
  • 한승범 (연세대학교 성형외과학 교실, 인체조직복원연구소) ;
  • 나동균 (연세대학교 성형외과학 교실, 인체조직복원연구소) ;
  • 유대현 (연세대학교 성형외과학 교실, 인체조직복원연구소)
  • Published : 2009.09.15

Abstract

Purpose: This study was conducted to establish the most effective method of cell therapy by comparing and analyzing the level of wound healing after various cell delivery methods. Methods: Human mesenchymal stem cells were administered using 5 different methods on full thickness skin defects which were deliberately created on the back of 4 - week old mice using a 8 mm punch. Different modes of administration, cell suspension, local injection, collagen GAG matrix seeding, fibrin, and hydrogel mix methods were used. In each experiment group, $4{\times}105$ mesenchymal stem cells were administered according to 5 deferent methods, and were not for the corresponding control group. Results: The wound healing rate was fastest in the local injection group. The wound healing rate was relatively slow in the collagen matrix group, however, the number of blood vessels or VEGF increased most in this group. Conclusion: For rapid wound healing through wound contraction, it is advantageous to administer MSC by the local injection method. For the healing process of a wide area, such as a burn, the seeding of cells to collagen matrix is thought to be effective.

Keywords

References

  1. Yamaguchi Y, Kubo T, Murakami T, Takahashi M, Hakamata Y, Kobayashi E, Yoshida S, Hosokawa K, Yoshikawa K, Itami S: Bone marrow cells differentiate into wound myofibroblasts and accelerate the healing of wounds with exposed bones when combined with an occlusive dressing. BR J Dermatol 152: 616, 2005 https://doi.org/10.1111/j.1365-2133.2005.06402.x
  2. Leary AG, Ogawa M: Blast cell colony assay for umbilical cord blood and adult bone marrow progenitors. Blood 69: 953, 1987
  3. Hows JM, Bradley BA, Marsh JC, Luft T, Coutinho L, Testa NG, Dexter TM: Growth of human umbilical cord blood in long term haemopoietic cultures. Lancet 340: 73, 1992 https://doi.org/10.1016/0140-6736(92)90396-K
  4. Lu L, Xiao M, Shen RN, Grigsby S, Broxmeyer HE: Enrichment, characterization, and responsiveness of single primitive CD34 human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential. Blood 81: 41, 1993
  5. Wagner JE, Broxmeyer HE, Byrd RL, Zehnbauer B, Schmeckpeper B, Shah N, Griffin C, Emanuel PD, Zuckerman KS, Cooper S, et al: Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment. Blood 79: 1874, 1992
  6. valbonesi M, Giannini G, Migliori F, Dalla Costa R, Dejana AM: Cord blood(CB) stem cells for wound repair. preliminary report of 2 cases. Transfus Apher Sci 30: 153, 2004 https://doi.org/10.1016/j.transci.2003.11.006
  7. Brunner G, Blakytny R: Extracellular regulation of TGF-beta activity in wound repair: growth factor latency as a sensor mechanism for injury. Thromb Haemost 92: 253, 2004
  8. Pandya NM, Dhalla NS, Santani DD: Angiogenesis-a new target for future therapy. Vascul Pharmacol 44: 265, 2006 https://doi.org/10.1016/j.vph.2006.01.005
  9. Byrne AM, Bouchier-Hayes DJ. Harmey JH: Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med 9: 777, 2005 https://doi.org/10.1111/j.1582-4934.2005.tb00379.x
  10. Carmeliet P: VEGF as a key mediator of angiogenesis in cancer. Oncology 69: 4, 2005 https://doi.org/10.1159/000088478
  11. Ho W, Tawil B, Dunn JC, Wu BM: The behavior of human mesenchymal stem cells in 3D fibrin clots: dependence on fibrinogen concentration and clot structure. Tissue Eng 12: 6, 2006